PLASMA IMMUNOREACTIVE CALCITONIN AND BONE-DISEASE IN DIALYZED PATIENTS

PLASMA IMMUNOREACTIVE CALCITONIN AND BONE-DISEASE IN DIALYZED PATIENTS

Opis bibliograficzny
Główni autorzy:	Heynen, G, Kanis, J, Earnshaw, M, Woods, C, Oliver, D, Ledingham, J, Walton, R, Russell, R
Format:	Journal article
Wydane:	1976

Podobne zapisy

EVIDENCE THAT ENDOGENOUS CALCITONIN PROTECTS AGAINST RENAL BONE-DISEASE
od: Heynen, G, i wsp.
Wydane: (1976)

CALCITONIN, BONE-DISEASE, AND CHRONIC RENAL-FAILURE
od: Cundy, T, i wsp.
Wydane: (1978)

The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
od: Kanis, J, i wsp.
Wydane: (1977)

CALCITONINS ROLE - REPLY
od: Kanis, J, i wsp.
Wydane: (1977)

Changes in histologic and biochemical indexes of bone turnover after bilateral nephrectomy in patients on hemodialysis. Evidence for a possible role of endogenous calcitonin.
od: Kanis, J, i wsp.
Wydane: (1977)

Correlation of clinical, biochemical and skeletal responses to 1alpha-hydroxyvitamin D3 in renal bone disease.
od: Kanis, J, i wsp.
Wydane: (1977)

Factors influencing the response to 1alpha-hydroxyvitamin D3 in patients with renal bone disease.
od: Kanis, J, i wsp.
Wydane: (1977)

VITAMIN-DS, MINERALS AND RENAL BONE-DISEASE
od: Kanis, J, i wsp.
Wydane: (1979)

Osteomalacia in renal disease.
od: Kanis, J, i wsp.
Wydane: (1980)

Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses.
od: Kanis, J, i wsp.
Wydane: (1979)

APPOSITIONAL RATES IN BONE IN PATIENTS WITH CHRONIC RENAL-DISEASE
od: Earnshaw, M, i wsp.
Wydane: (1979)

An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease.
od: Walton, R, i wsp.
Wydane: (1975)

Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.
od: Kanis, J, i wsp.
Wydane: (1977)

Loss of metacarpal and iliac bone in chronic renal failure: influence of haemodialysis, parathyroid activity, type of renal disease, physical activity and heparin consumption.
od: Henderson, R, i wsp.
Wydane: (1979)

Histological measurements in Paget's disease of bone.
od: Walton, R, i wsp.
Wydane: (1977)

VITAMIN-D IN CHRONIC RENAL-FAILURE
od: Kanis, J, i wsp.
Wydane: (1979)

THERAPEUTIC ADVANTAGE OF 1-ALPHA-HYDROXYLATED COMPOUNDS OVER VITAMIN-D
od: Kanis, J, i wsp.
Wydane: (1977)

Dialyzer Reuse Impact on Dialyzer Efficiency, Patient Morbidity and Mortality and Cost Effectiveness
od: Mitwalli Ahmed, i wsp.
Wydane: (2001-01-01)

THE PATHO-PHYSIOLOGY OF HYPERCALCEMIA
od: Kanis, J, i wsp.
Wydane: (1980)

Resistance of dialyzed patients to erythropoietin
od: Michelle Teodoro Alves, i wsp.
Wydane: (2015-06-01)

Diffusion in Tube Dialyzer
od: Yohannes Nigatie
Wydane: (2017-09-01)

Assessment of dialyzer surface in online hemodiafiltration; objective choice of dialyzer surface area
od: Francisco Maduell, i wsp.
Wydane: (2015-05-01)

Estimation of calcitonin and calcitonin gene-related peptide-α in bone calcification in quail during laying period
od: Hadeel M. Hameed, i wsp.
Wydane: (2025-01-01)

RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN
od: Russell, R, i wsp.
Wydane: (1979)

Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
od: Henderson, R, i wsp.
Wydane: (1974)

Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children
od: Esra Baskin, i wsp.
Wydane: (2004-01-01)

Sleep disorders in chronically dialyzed patients
od: Agnieszka Pluta, i wsp.
Wydane: (2018-10-01)

Sleep disorders in chronically dialyzed patients
od: Agnieszka Pluta, i wsp.
Wydane: (2018-10-01)

Carboxypeptidase B1 in dialyzed chronic kidney disease patients
od: Matej Stančík, i wsp.
Wydane: (2025-02-01)

Efficacy of Calcitonin on Bone Healing in Guinea Pigs
od: MA Erfani, i wsp.
Wydane: (2006-07-01)

Hemodynamic effects of succinate-containing dialyzing solution
od: A V Smirnov, i wsp.
Wydane: (2015-06-01)

The importance of psychological support for end-stage renal disease dialyzed patients
od: M. Regaya, i wsp.
Wydane: (2021-04-01)

NLRP3 inflammasome activation in dialyzed chronic kidney disease patients.
od: Simona Granata, i wsp.
Wydane: (2015-01-01)

Dietary intake of tyrosine and phenylalanine, and p-cresyl sulfate plasma levels in non-dialyzed patients with chronic kidney disease
od: Andressa Louzada Frauche Fernandes, i wsp.

Potential study of regenerating waste dialyzer
od: Maryani, Basri
Wydane: (2014)

Regeneration and recycling hemodialysis membrane dialyzer
od: Siti Norsita, Mohd Rawi
Wydane: (2013)

Dialyzer reuse; effect on efficiency and biocompatibility
od: Atef H Huzayin, i wsp.
Wydane: (1999-01-01)

Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
od: Jingbo Xie, i wsp.
Wydane: (2020-01-01)

PERCUTANEOUS TREATMENT OF ANEURYSMAL BONE CYST WITH CALCITONIN AND METHYLPREDNISOLONE
od: Marcelo Bragança dos Reis Oliveira, i wsp.
Wydane: (2018-10-01)

Calcitonin in osteogenesis imperfecta.
od: Smith, R, i wsp.
Wydane: (1973)